168 related articles for article (PubMed ID: 7643114)
1. Selective inhibition of cholesterol biosynthesis in brain cells by squalestatin 1.
Crick DC; Suders J; Kluthe CM; Andres DA; Waechter CJ
J Neurochem; 1995 Sep; 65(3):1365-73. PubMed ID: 7643114
[TBL] [Abstract][Full Text] [Related]
2. Effect of squalene synthase inhibition on the expression of hepatic cholesterol biosynthetic enzymes, LDL receptor, and cholesterol 7 alpha hydroxylase.
Ness GC; Zhao Z; Keller RK
Arch Biochem Biophys; 1994 Jun; 311(2):277-85. PubMed ID: 7911291
[TBL] [Abstract][Full Text] [Related]
3. Squalestatin 1, a potent inhibitor of squalene synthase, which lowers serum cholesterol in vivo.
Baxter A; Fitzgerald BJ; Hutson JL; McCarthy AD; Motteram JM; Ross BC; Sapra M; Snowden MA; Watson NS; Williams RJ
J Biol Chem; 1992 Jun; 267(17):11705-8. PubMed ID: 1601846
[TBL] [Abstract][Full Text] [Related]
4. Farnesol is utilized for protein isoprenylation and the biosynthesis of cholesterol in mammalian cells.
Crick DC; Andres DA; Waechter CJ
Biochem Biophys Res Commun; 1995 Jun; 211(2):590-9. PubMed ID: 7794274
[TBL] [Abstract][Full Text] [Related]
5. Effect of squalestatin 1 on the biosynthesis of the mevalonate pathway lipids.
Thelin A; Peterson E; Hutson JL; McCarthy AD; Ericsson J; Dallner G
Biochim Biophys Acta; 1994 Dec; 1215(3):245-9. PubMed ID: 7811707
[TBL] [Abstract][Full Text] [Related]
6. Squalene synthase inhibition alters metabolism of nonsterols in rat liver.
Keller RK
Biochim Biophys Acta; 1996 Oct; 1303(3):169-79. PubMed ID: 8908150
[TBL] [Abstract][Full Text] [Related]
7. Regulation of cholesterol 7 alpha-hydroxylase expression by sterols in primary rat hepatocyte cultures.
Doerner KC; Gurley EC; Vlahcevic ZR; Hylemon PB
J Lipid Res; 1995 Jun; 36(6):1168-77. PubMed ID: 7665995
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacological control of biosynthesis pathway of mevalonate: effect on the proliferation of arterial smooth muscle cells].
Corsini A; Arnaboldi L; Quarato P; Ferri N; Granata A; Fumagalli R; Paoletti R
C R Seances Soc Biol Fil; 1997; 191(2):169-94. PubMed ID: 9255346
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of the inhibition of rat and tobacco squalene synthase by squalestatins.
Fulton DC; Tait M; Threlfall DR
Phytochemistry; 1995 Mar; 38(5):1137-41. PubMed ID: 7766395
[TBL] [Abstract][Full Text] [Related]
10. Competitive inhibition of squalene synthetase by squalestatin 1.
Hasumi K; Tachikawa K; Sakai K; Murakawa S; Yoshikawa N; Kumazawa S; Endo A
J Antibiot (Tokyo); 1993 Apr; 46(4):689-91. PubMed ID: 8501015
[No Abstract] [Full Text] [Related]
11. Protein farnesyltransferase: measurement of enzymatic activity in 96-well format using TopCount microplate scintillation counting technology.
Harwood HJ
Anal Biochem; 1995 Apr; 226(2):268-78. PubMed ID: 7793628
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of mammalian squalene synthetase activity by zaragozic acid A is a result of competitive inhibition followed by mechanism-based irreversible inactivation.
Lindsey S; Harwood HJ
J Biol Chem; 1995 Apr; 270(16):9083-96. PubMed ID: 7721822
[TBL] [Abstract][Full Text] [Related]
13. The squalestatins: novel inhibitors of squalene synthase. Enzyme inhibitory activities and in vivo evaluation of C1-modified analogues.
Procopiou PA; Bailey EJ; Bamford MJ; Craven AP; Dymock BW; Houston JG; Hutson JL; Kirk BE; McCarthy AD; Sareen M
J Med Chem; 1994 Sep; 37(20):3274-81. PubMed ID: 7932554
[TBL] [Abstract][Full Text] [Related]
14. Regulation of rat hepatic cytochrome P450 expression by sterol biosynthesis inhibition: inhibitors of squalene synthase are potent inducers of CYP2B expression in primary cultured rat hepatocytes and rat liver.
Kocarek TA; Kraniak JM; Reddy AB
Mol Pharmacol; 1998 Sep; 54(3):474-84. PubMed ID: 9730906
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of cholesterol synthesis by squalene synthase inhibitors does not induce myotoxicity in vitro.
Flint OP; Masters BA; Gregg RE; Durham SK
Toxicol Appl Pharmacol; 1997 Jul; 145(1):91-8. PubMed ID: 9221828
[TBL] [Abstract][Full Text] [Related]
16. Zaragozic acids: a family of fungal metabolites that are picomolar competitive inhibitors of squalene synthase.
Bergstrom JD; Kurtz MM; Rew DJ; Amend AM; Karkas JD; Bostedor RG; Bansal VS; Dufresne C; VanMiddlesworth FL; Hensens OD
Proc Natl Acad Sci U S A; 1993 Jan; 90(1):80-4. PubMed ID: 8419946
[TBL] [Abstract][Full Text] [Related]
17. The squalestatins: inhibitors of squalene synthase. Enzyme inhibitory activities and in vivo evaluation of C3-modified analogues.
Procopiou PA; Cox B; Kirk BE; Lester MG; McCarthy AD; Sareen M; Sharratt PJ; Snowden MA; Spooner SJ; Watson NS; Widdowson J
J Med Chem; 1996 Mar; 39(7):1413-22. PubMed ID: 8691471
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory activity to protein prenylation and antifungal activity of zaragozic acid D3, a potent inhibitor of squalene synthase produced by the fungus, Mollisia sp. SANK 10294.
Tanimoto T; Ohya S; Tsujita Y
J Antibiot (Tokyo); 1998 Apr; 51(4):428-31. PubMed ID: 9630865
[TBL] [Abstract][Full Text] [Related]
19. The squalestatins, novel inhibitors of squalene synthase produced by a species of Phoma. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological activity.
Dawson MJ; Farthing JE; Marshall PS; Middleton RF; O'Neill MJ; Shuttleworth A; Stylli C; Tait RM; Taylor PM; Wildman HG
J Antibiot (Tokyo); 1992 May; 45(5):639-47. PubMed ID: 1624366
[TBL] [Abstract][Full Text] [Related]
20. Squalestatin 1-inducible expression of rat CYP2B: evidence that an endogenous isoprenoid is an activator of the constitutive androstane receptor.
Kocarek TA; Mercer-Haines NA
Mol Pharmacol; 2002 Nov; 62(5):1177-86. PubMed ID: 12391282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
